Your browser doesn't support javascript.
loading
Corrigendum to 'Phosphorylated Rasal2 facilitates breast cancer progression': [EBioMedicine 50 (2019) 144-155].
Wang, Xuan; Qian, Christopher; Yang, Yinlong; Liu, Meng-Yue; Ke, Ya; Qian, Zhong-Ming.
Afiliação
  • Wang X; Institute of Translational & Precision Medicine, Nantong University, 19 Qi Xiu Road, Nantong, JS 226019, China; Department of Pharmacology and Biochemistry, Fudan University School of Pharmacy, 826 Zhangheng Road, Pu Dong, Shanghai 201203, China.
  • Qian C; School of Biomedical Sciences and Gerald Choa Neuroscience Centre, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, NT, Hong Kong.
  • Yang Y; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200000, China.
  • Liu MY; Institute of Translational & Precision Medicine, Nantong University, 19 Qi Xiu Road, Nantong, JS 226019, China.
  • Ke Y; School of Biomedical Sciences and Gerald Choa Neuroscience Centre, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, NT, Hong Kong.
  • Qian ZM; Institute of Translational & Precision Medicine, Nantong University, 19 Qi Xiu Road, Nantong, JS 226019, China; Department of Pharmacology and Biochemistry, Fudan University School of Pharmacy, 826 Zhangheng Road, Pu Dong, Shanghai 201203, China. Electronic address: qianzhongming@fudan.edu.cn.
EBioMedicine ; 62: 103127, 2020 Dec.
Article em En | MEDLINE | ID: mdl-33181465

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: EBioMedicine Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: EBioMedicine Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China